News


Resident News

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

By JLABS

Read full story
Resident News

Tatch raises $4.25M to build a patch that helps diagnose sleep disorders

By JLABS

Read full story
Resident News

Pendulum launched new product, probiotic for those w/ T2 Diabetes

By JLABS

Read full story
Other news

Announcing the Next in Naturals QuickFire Challenge on Immune-Support

By JLABS

Read full story
Other news

Announcing the Next in Naturals QuickFire Challenge on Immune-Support

By JLABS

Read full story
Resident News

Nkarta files for IPO

By JLABS

Read full story
Resident News

Biotech GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Fierce 15 winner Ideaya

By JLABS

Read full story
Resident News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story
Resident News

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

By JLABS

Read full story
Resident News

Versatope in Collaboration to Develop Universal Flu Vaccine

By JLABS

Read full story
Resident News

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story
Other news

The Electronic Patient Visit Assessment (ePVA) and Nationwide Children’s Hospital Named Awardees in Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology

By JLABS

Read full story
Resident News

Immunoscape studying immune response to Covid-19

By JLABS

Read full story
Resident News

Holmusk Announces Closing of $21.5 Million Series A Funding Round, Led by Optum Ventures & Health Catalyst Capital

By JLABS

Read full story
Other news

Announcing the Drug-Resistant Tuberculosis QuickFire Challenge

By JLABS

Read full story